Results 1 to 10 of about 18 (18)

Color dilution alopecia in a Yorkshire

Brazilian Journal of Veterinary Pathology, 2022
A 1-year-old female Yorkshire terrier was presented to the clinic for a second opinion regarding its poor hair coat condition. According to the owner, the dog has been showing that appearance since the moment it was adopted, at 8 months of age. The owner
Tomás Rodrigues Magalhães, Filipe Fontes Pinto   +1 more
doaj   +1 more source

Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs

Parasites & Vectors, 2023
Background Poor owner compliance with monthly control measures means that dogs in Australia can remain susceptible to infestations with fleas, present throughout the whole year, and brown dog ticks, which thrive in tropical and subtropical areas.
Petr Fisara, Frank Guerino
doaj   +1 more source

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

Parasites & Vectors, 2014
Background Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Nadja Rohdich, Rainer KA Roepke, Eva Zschiesche   +2 more
doaj   +1 more source

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats

Parasites & Vectors, 2018
Background Fluralaner provides efficacy against feline ectoparasites following topical administration. Moxidectin is routinely used to treat gastrointestinal nematode infections and prevent heartworm disease caused by Dirofilaria immitis. Praziquantel is
Feli M. Walther, Petr Fisara, Rainer K. A. Roepke   +2 more
doaj   +1 more source

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)

Parasites & Vectors, 2014
Background Bravecto™ (fluralaner; MSD Animal Health) is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose.
Feli M Walther, Petr Fisara, Mark J Allan, Rainer KA Roepke, Martin C Nuernberger   +4 more
doaj   +1 more source

Efficacy of orally administered fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

Parasites & Vectors, 2015
Background This laboratory study compared the efficacy of Bravecto™ (fluralaner), formulated as a chewable tablet, with the efficacy of Advocate® (imidacloprid/moxidectin), formulated for topical administration, against naturally acquired generalized ...
Josephus J Fourie, Julian E Liebenberg, Ivan G Horak, Janina Taenzler, Anja R Heckeroth, Regis Frénais   +5 more
doaj   +1 more source

Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration

Parasites & Vectors, 2014
Background Fluralaner is a novel systemic insecticide and acaricide that provides long acting efficacy in dogs after a single oral treatment. This study investigated the safety of oral administration of fluralaner in chewable tablets to dogs at the ...
Feli M Walther, Mark J Allan, Rainer KA Roepke, Martin C Nuernberger   +3 more
doaj   +1 more source

A systematic review of fluralaner as a treatment for ectoparasitic infections in mammalian species [PDF]

PeerJ
Fluralaner (Bravecto™) is a novel isoxazoline ectoparasiticide used for controlling ectoparasites of domestic mammals and is increasingly being used on wildlife. The aim of this systematic review was to evaluate the efficacy, pharmacokinetics, and safety
Yuanting Jiang, Julie M. Old
doaj   +2 more sources

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

Parasites & Vectors, 2014
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical ...
Feli M Walther, Allan J Paul, Mark J Allan, Rainer KA Roepke, Martin C Nuernberger   +4 more
doaj   +1 more source

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs

Parasites & Vectors, 2017
Background The clinical efficacy of fluralaner chewable tablets (Bravecto™, MSD Animal Health) against naturally acquired Linognathus setosus infestations on dogs was evaluated compared with permethrin (Exspot®, MSD Animal Health) treatment.
Heike Kohler-Aanesen, Seppo Saari, Rob Armstrong, Karine Péré, Janina Taenzler, Eva Zschiesche, Anja R Heckeroth   +6 more
doaj   +1 more source